2025-12-05 2025-12-05 , online online, 1,330 € zzgl. MwSt. Dr. Christopher Brückner https://www.forum-institut.de/seminar/26051130-spc-2026-the-supplementary-protection-certificates-update/referenten/26/26_05/26051130-online-course-spc-update_brueckner-christopher.jpg SPC 2026: The Supplementary Protection Certificates Update

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course
  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Teva v MSD: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this online course is intended for you. Prior knowledge of patents is a requisite.
The objectives of your online course
In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers.

Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As a wide-reaching reform of the SPC law is impending with, among others, a unitary SPC, our speaker will give you an overviewand will explain to you what changes can be expected.
Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Course - Supplementary Protection Certificates, SPC and the ECJ

SPC 2026: The Supplementary Protection Certificates Update

EU Reform And Case-Law

Benefits
  • Latest developments in brief
  • Optional booking: pre-course

Webcode 26051130

Jetzt buchen

JETZT Buchen
Referent

Dr. Christopher Brückner

Patent Attorney/Pharmacist, Brückner IP, Munich (Germany)

Dr Christopher Brückner is a German and European Patent Attorney and Pharmacist with Brückner IP based in Munich, Germany. He is the author of the standard reference commentary on SPC law. In addition he is coauthor of the EPC commentary Singer/Stauder. He is a sought-after author, lecturer and commentator in this field. In 2012, the Düsseldorf Higher Regional Court appointed Christopher as an independent legal expert in a patent dispute in the pharmaceutical field. In 2016, the Max Planck Institute for Innovation and Competition requested that Dr Brückner participates in the preparation of a study commissioned by the EU. The purpose of the study was to determine whether the current EU Regulation 469/2009 for SPCs meets today's technical and legal requirements.

Alles auf einen Blick

Termin

06 - 07/05/2026

06 - 07/05/2026

Zeitraum

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET
Veranstaltungsort

online

online

Downloads
PROSPEKT
PROSPEKT
Gebühr

Event - 1,330€ plus tax
The fee includes the 'live' participation via Internet, the access to the learning platform as well as course documentation for download. € 390 (+ German VAT) - pre-course (optional booking)
€ 1,330 (+ German VAT) - advanced course



OPTIONS
Pre-Course: Introduction to SPC
+390,00 €

Event - 1,330€ plus tax
The fee includes the 'live' participation via Internet, the access to the learning platform as well as course documentation for download. € 390 (+ German VAT) - pre-course (optional booking)
€ 1,330 (+ German VAT) - advanced course



OPTIONS
Pre-Course: Introduction to SPC
+390,00 €

Inhouse-Angebote
Inhouse-Angebot anfordern
Inhouse-Angebot anfordern

Jetzt buchen

Your contact

Jean-Claude Alexandre Ho, LL.M.
Lawyer, Conference Manager

+49 6221 500-675
jc.alexandreho@forum-institut.de

Details

Our speaker, one of the leading SPC experts in Europe, will discuss the SPC referrals to the ECJ with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice.

The contents of your online course

  • Key issues of the Supplementary Protection Certificates
  • SPC reform, e.g. unitary SPC
  • ECJ referrals from Medeva to Teva v MSD: context, background and interpretation
  • Impact of the referrals on application practice and national court practice
  • Pending referrals


Who should attend
Do you work in a corporate patent or IP department, or as a patent attorney in private practice and need an update on the ECJ's SPC case-law?

Then, this online course is intended for you. Prior knowledge of patents is a requisite.

The objectives of your online course

In order to understand how to deal with supplementary protection certificates, one needs not only to understand the regulations but also the respective case-law. Thus the European Court of Justice has issued many important SPC decisions in the last few years: Medeva, Neurim, Actavis. The latest ones have raised more questions than have given answers.

Our speaker, one of the leading SPC experts in Europe, will discuss the referrals with you. He will put the decisions in context and will show you the consequences for national court practice and for your application practice. Dr Brückner will also give some hints as to pending referrals and yet unsolved questions which might be the subject of future referrals. As a wide-reaching reform of the SPC law is impending with, among others, a unitary SPC, our speaker will give you an overviewand will explain to you what changes can be expected.

Your benefit

  • You will be up to date with the case-law of the European Court of Justice on supplementary protection certificates
  • You will get a better understanding of the articles of the regulations
  • You will understand the impact of the unitary patent and the Unified Patent Court on supplementary protection certificates
  • You will be up to date with regards to the EU SPC Reform

Detailed programme

Pre-course: starts at 13:00 CET, ends at 17:15 CET I Advanced course: starts at 09:00 CET, ends at 17:00 CET

Introduction to the basic terms
  • Structure of the EU SPC Regulation for Medicinal Products
  • Product - relevant deadlines - basic patent - relevant marketing authorization

Fundamental practical questions
  • What can be protected?
  • Application for a certificate based on third parties' authorisation
  • Date of grant of the basic patent and the marketing authorization

SPC key issues and SPC reform (Unitary SPC etc.)

Medeva, Eli Lilly, Actavis and Georgetown II referrals: laying the ground

From Merck vs Sigma to Genmab
  • Merck v Sigma (C-579/13), Pfizer Ireland (C-681/16): referrals on Specific Mechanism
  • Synflorix (C-631/13): definition of adjuvant
  • Boehringer (C-577/13): combination claimed in second patent
  • Forsgren (C-631/13): covalent binding of a biologic product
  • Seattle Genetics (C-471/14): date of market authorisation
  • F. Hoffmann - La Roche (C-572/15): duration of an SPC issued under national law
  • Incyte (C-492/16): date of expiry of an SPC
  • MSD (C-567/16): end of procedure notice equivalent to market authorisation?
  • Teva v Gilead (C-121/17): product protected by a basic patent in force
  • Boston Scientific (C-527/17): no SPCs for CE-marked devices
  • Abraxis (C-443/17): first marketing authorisation for new formulations
  • QH/Royalty Pharma (C 650/17): individualized embodiment
  • Santen v INPI (C-673/18): no SPC for new therapeutic applications
  • Mylan (C-473/22): liability for enforcing a later invalid patent
  • Genmab (C-181/24): second marketing authorisation
  • Teva v MSD (C-119/22): "product" in Art 3(a) and Art 3(c)

Pending referrals*: what to expect
  • Halozyme (C-456/24): "active ingredient"
(*Further referrals will be covered if they are pending by the day of the course.)

More informations

Agenda

The agenda hast been adapted speifically to the medium and the respective seminar.

It is as follows:

Pre-course: Introduction to SPC
14 May 2025 I Online
starts at 13:00 CET, ends at 17:15 CET
breaks at 14:15 and 15:45 CET

Advanced course: SPC Update
15 May 2025 I Online
starts at 09:00 CET, ends at 17:00 CET
breaks at 10:30, 12:15 and 15:30 CET

Introduction to SPC

Attendees without prior SPC knowledge/ education are advised to attend the introduction to SPC pre-course on 14 May 2025.

This training as in-house course

The topic of this training - Supplementary Protection Certificates - can also be offered as a tailored course for your organisation. Just send an email to jc.alexandreho@foruminstitut.de with further details for a quote.

13 hours CPD/pursuant to Section 15 FAO

At this event, participants will receive a certificate confirming 13 hours CPD/pursuant to Section 15 FAO (German Rules on Certified Specialist Lawyers].

Benefits of a FORUM Institut training course

FORUM Institut’s all-in-one training platform uses the latest teaching methods.
All our online training courses take place in the Learning Space, our holistic learning environment with many features that promote effective and sustainable learning.

  • Live and interactive learning on our Learning Space training platform
  • A platform with many features: events rooms, chat, course agendas and documents, surveys, workshop rooms and much more
  • Easy surveys with Slido
  • ‘Deluxe’ chat: group chats, one-to-one chats, one-to-one video chats
  • A central repository for documents and media
  • Other services and apps such as Padlet and Mentimeter available directly on the platform
  • The perfect marriage of teaching methods and technology
  • High level of interactivity with plenty of opportunity for questions
  • Continuous support throughout the event to ensure the most effective learning
  • Free technical pre-meeting to start off your training on the right foot

Technical requirements

You need a reliable Internet connection to take part in our online events. To have the best possible learning experience, we recommend that you use the latest version of the Microsoft Edge or Google Chrome browsers. You will need a headset, loudspeaker or telephone to play the audio. Further information is available here. Please check beforehand that your microphone or headset and camera are working properly. Do not access our services from a VPN since there are issues with the audio over such connections.

We have integrated Zoom video conferencing software into our Learning Space for our online training courses. If you are not authorised to use Zoom, please get in touch with us so we can make alternative arrangements for you to take part in our online training.

Free pre-meeting and technology check

You can attend one of our pre-meetings and explore our Learning Space free of charge. Registration is not required. You can find available dates for a pre-meeting in your customer portal. Click the green ‘Participate’ button in the pre-meeting in the customer portal and you will be redirected to the Learning Space.

The pre-meeting gives you the opportunity to explore our Learning Space and to familiarise yourself with the technology to start off your online training on the right foot. This is a non-binding offer for all our customers and not a prerequisite for participation. If a pre-meeting date does not suit you but you would still like a technology check, please contact us.

This distinguishes our events

Very informative and thought-provoking.

Very informative and thought-provoking.

Recommendations

How to Protect And Manage Trade Secret Assets

This online course provides essential understanding of statutory and contractual trade secret protection especially agai...

19.03.2026 in
Details

IP Agreements: Patent License Agreements

Participants, doing business in a complex multi-jurisdictional environment, will be enabled to address difficult situati...

19.03.2026 in
Details

IP Agreements: Research and Development Agreements

Participants, doing business in a complex multi-jurisdictional environment, will be enabled to address difficult situati...

18.03.2026 in
Details

GenAI Patent Munich Spring Camp

Join our two-day course and discover how to revolutionize your patent work with the power of generative AI. This immersi...

24. - 25.03.2026 in München
Details

e-Learning: Patent Portfolio Generation and Management

This e-learning will familiarise you with patent portfolio management.

31.12.2025 in
Details

Go forward

White paper: Inside the Patent Factory

Download this whitepaper and get insights on the patent creation process.

Details
White paper: Inside the Patent Factory
White paper on generative AI in patents

Discover the future of patent work in the age of artificial intelligence in this expert interview with Sebastian Goebel.

Details
White paper:
White paper: IP strategy - where to start

Download this whitepaper with the views of ~400 IP professionals.

Details
White paper: IP strategy

Testimonials

Testimonial
'This is really helpful for building our IP department. What I liked most: the practical applicability of the course content. Excellent course for portfolio managers.'

Jan-Willem Louwaard, IP Senior Manager

Tenaris Connections


'The course has met my expectations. I liked that the course was practical.'

Jean-Christophe Raboin, European Patent Attorney

Total


'Good insight in portfolio management, practical tools, templates.'

European Patent Attorney